Libentech
Libentech develops anti-cancer viruses through the oncolytic effect of LVP-K.
Operating in biotechnology, health care, health diagnostics, medical device based in Asia-Pacific (APAC), Libentech was founded in 2020.
Within the biotechnology, health care, health diagnostics, medical device space, the company focuses on its core offering rather than a broad product line.
Asia-Pacific (APAC) is where the company is located.
The company is listed at the Pre_Seed stage of development.
| Sector | Biotechnology, Health Care, Health Diagnostics, Medical Device |
|---|---|
| Headquarters | Asia-Pacific (APAC) |
| Founded | 2020 |
| Stage | pre_seed |
Website: libentech.kr
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account